Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.22.1 (
DNase II
)
429
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Many cells die during mammalian development and are engulfed by macrophages. In
DNase II
(-/-) embryos, the TUNEL-positive DNA of apoptotic cells is left undigested in macrophages, providing a system for studying programmed cell death during mouse development. Here, we showed that an
Apaf-1
-null mutation in the
DNase II
(-/-) embryos greatly reduced the number of macrophages carrying DNA at E11.5. However, at later stages of the embryogenesis, a significant number of macrophages carrying undigested DNA were present in
Apaf-1
(-/-) embryos, indicating that cells died and were engulfed in an
Apaf-1
-independent manner. In most tissues of the
Apaf-1
(-/-) embryos, no processed caspase-3 was detected, and the DNA of dead cells accumulated in the macrophages appeared intact. Many nonapoptotic dead cells were found in the tail of the
Apaf-1
(-/-) embryos, suggesting that the
Apaf-1
-independent programmed cell death occurred, and these dead cells were engulfed by macrophages. In contrast, active caspase-3 was detected in E14.5 thymus of
Apaf-1
(-/-) embryos. Treatment of fetal thymocytes with staurosporine, but not etoposide, induced processing of procaspases 3 and 9, indicating that the E14.5 thymocytes have the ability to undergo caspase-dependent apoptosis in an
Apaf-1
-independent manner. Thus, programmed cell death in mouse development, which normally proceeds in an efficient
Apaf-1
-depenent mechanism, appears to be backed up by
Apaf-1
-independent death systems.
...
PMID:Apaf-1-independent programmed cell death in mouse development. 1996 21